知镜 Cognispect · 医学文献与研究工作台

PLA2G2F/lysoplasmalogen axis links epidermal lipid metabolism to type 2 inflammation and itch in atopic dermatitis.

Miki Y, Higashisaka N, Inubushi H, Hirabayashi N, Watanabe K, Fukui S, Onitsuka M, Fukaura C, Ogawa-Momohara M, Tanahashi K, Nagasaki Y, Takeichi T, Akiyama M, Murakami M, Yamamoto K.
Frontiers in immunology · 2026-09-07 · PMID 42769163

文献摘要

Atopic dermatitis is a chronic inflammatory skin disease characterized by type 2 immune responses and severe itching; however, the molecular mechanisms linking lipid metabolism to epithelial-immune signaling remain incompletely understood. Herein, we show that group IIF secreted phospholipase A 2 (PLA2G2F), which is induced by type 2 cytokines and selectively generates plasmalogen-derived lysophosphatidylethanolamine (lysoplasmalogen; P-LPE) in keratinocytes, contributes to the aggravation of atopic dermatitis and itching. Genetic deletion of Pla2g2f attenuated IL-33 expression in keratinocytes and reduced epidermal hyperplasia, serum IgE levels, type 2 inflammation and scratching behavior, without directly affecting neuronal structure and function, in a mouse model of atopic dermatitis. Topical application of a secreted PLA 2 inhibitor or forcible enzymatic degradation of P-LPE suppressed the itch response in wild-type mice, whereas exogenous P-LPE partially restored scratching behavior in Pla2g2f -deficient mice. Importantly, P-LPE levels were significantly elevated in the stratum corneum of patients with atopic dermatitis and positively correlated with disease severity. Collectively, the present study highlights that the PLA2G2F/P-LPE axis, originally identified in psoriasis, is a key regulator that connects epidermal lipid metabolism to IL-33-mediated type 2 inflammation and itching, suggesting that this pathway could be a novel therapeutic target and biomarker of this disease.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。